Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., No. 24-1402 (Fed. Cir. Apr. 12, 2024)

Dismissed
General / Procedural
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 24-1402
Decided
April 12, 2024
Judge
Per curiam
Document
Nonprecedential Opinion
Length
2 pages
Download Opinion (PDF)

NOTE: This order is nonprecedential. United States Court of Appeals

for the Federal Circuit REGENERON PHARMACEUTICALS, INC.,

Plaintiff-Appellant

v.

MYLAN PHARMACEUTICALS INC., BIOCON

BIOLOGICS INC.,

Defendants-Cross-Appellants

AMGEN USA, INC.,

Defendant

2024-1402, 2024-1405

Appeals from the United States District Court for the Northern District of West Virginia in No. 1:22-cv-00061-TSK-JPM, Chief Judge Thomas S. Kleeh.

Before CHEN, LINN, and HUGHES, Circuit Judges.

PER CURIAM.

O R D E R

Following this court’s February 22, 2024 show cause order, the parties agree that the court lacks jurisdiction over both the appeal and cross-appeal from the district court’s December 27, 2023 decision resolving fewer than all2 2 REGENERON PHARMACEUTICALS, INC. v. MYLAN

PHARMACEUTICALS INC. claims at issue. Under the circumstances, we agree and conclude that dismissal is appropriate.

Accordingly,

IT IS ORDERED THAT:

(1) Appeal Nos. 2024-1402 and 2024-1405 are dismissed.

(2) Each party shall bear its own costs.

FOR THE COURT

Figure on page 2 of the opinion

April 12, 2024 Date ISSUED AS A MANDATE: April 12, 2024

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., No. 24-1402 (Fed. Cir. Apr. 12, 2024).

Record ID
CAFC-24-1402-20240412
Permalink
https://patentcasewatch.com/opinions/CAFC-24-1402-20240412

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.

Source: Federal Circuit opinions and orders · retrieved August 15, 2026 · Report an error